Taken together, our findings provide compelling evidence that silencing METTL3 in HCC cells leads to elevated ROS levels and impaired nucleotide synthesis, ultimately resulting in cell cycle arrest and inhibition of HCC growth. Here, METTL3 is linked to hepatocellular carcinoma.